Version 5.4
Mus musculus Protein: Psma3
Summary
InnateDB Protein IDBP-540245.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Psma3
Protein Name proteasome (prosome, macropain) subunit, alpha type 3
Synonyms Lmpc8;
Species Mus musculus
Ensembl Protein ENSMUSP00000125739
InnateDB Gene IDBG-146271 (Psma3)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
They are also associated with 175 interaction(s) predicted by orthology.
Experimentally validated
Total 5 [view]
Protein-Protein 5 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 175 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004175 endopeptidase activity
GO:0005515 protein binding
Biological Process
GO:0006511 ubiquitin-dependent protein catabolic process
Cellular Component
GO:0005634 nucleus
GO:0005839 proteasome core complex
GO:0019773 proteasome core complex, alpha-subunit complex
Protein Structure and Domains
PDB ID MGI:104883
InterPro IPR000426 Proteasome alpha-subunit, N-terminal domain
IPR029055 Nucleophile aminohydrolases, N-terminal
PFAM PF10584
PRINTS
PIRSF
SMART SM00948
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E0CZ34
UniProt Splice Variant
Entrez Gene 19167
UniGene Mm.468204
RefSeq
MGI ID
MGI Symbol Psma3
OMIM
CCDS
HPRD
IMGT
EMBL AC132325
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca